Speaker illustration

Mr Dragan Opacic

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

The metabolic modulator trimetazidine inhibits AF-induced atrial structural remodelling

Event: EHRA 2018

Topic: Atrial Fibrillation - Pathophysiology and Mechanisms

Session: Basic Science

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb